2018
DOI: 10.1200/jco.2018.36.15_suppl.e19510
|View full text |Cite
|
Sign up to set email alerts
|

Self-stated and actual practice patterns of general medical oncologists (MO) regarding the use of predictive biomarkers to guide treatment for patients (pts) with chronic lymphocytic leukemia (CLL).

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles